Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55.
about
Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and DevelopmentThe natural product magnolol as a lead structure for the development of potent cannabinoid receptor agonistsPharmacological evaluation of synthetic cannabinoids identified as constituents of spice.Novel psychoactive substances of interest for psychiatry.Identification of the GPR55 antagonist binding site using a novel set of high-potency GPR55 selective ligands.The therapeutic potential of orphan GPCRs, GPR35 and GPR55.New approaches in the design and development of cannabinoid receptor ligands: multifunctional and bivalent compounds.Is there a potential of misuse for Magnolia officinalis compounds/metabolites?Neuroprotective effects of honokiol: from chemistry to medicine.Synthesis of 2,2'-biphenols through direct C(sp(2))-H hydroxylation of [1,1'-biphenyl]-2-ols.Polyethylene glycol-based ultrasound-assisted extraction of magnolol and honokiol from Cortex Magnoliae Officinalis.Uncovering the Mechanisms of Chinese Herbal Medicine (MaZiRenWan) for Functional Constipation by Focused Network Pharmacology Approach.Pharmacological evaluation of new constituents of "Spice": synthetic cannabinoids based on indole, indazole, benzimidazole and carbazole scaffolds.Bicyclic imidazole-4-one derivatives: a new class of antagonists for the orphan G protein-coupled receptors GPR18 and GPR55
P2860
Q26776241-F55117A1-AD11-425E-8A3B-FAE9C21BFE16Q28534752-C2ECF38C-286A-4671-95A2-32CD770824E3Q34534443-721AF8D4-0178-4274-88B2-D727AA3FE179Q34667835-B5031A4C-AD3C-4DD6-BACF-062769CEE94AQ35052556-B9FC69AC-843B-4060-B530-D6DEA7AC6398Q35425244-B7C934BB-4182-4D2D-961E-AF40A438E0AFQ38395251-7684317A-19BD-42C9-8684-D7E5FEC4AE42Q38682461-9A0C4540-2CEC-4B10-9C58-556BF9A88DA7Q48150702-E31EB736-D619-4D01-9030-3DE88B03D49BQ50222298-D048EA8B-27DE-43B1-BF3D-EED39E86F6CAQ50449825-1A5B5B7D-EB4A-435B-B894-DD02DF4ADC9AQ52597677-9C63129E-AE15-4E58-981B-6BAFD4122088Q55410271-2A96FC4E-1BED-4229-B231-FFAB588A074FQ56593641-445DE39E-47B1-488C-869C-939071E2F340
P2860
Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Magnolia Extract, Magnolol, an ...... Blockade of the Related GPR55.
@en
Magnolia Extract, Magnolol, an ...... Blockade of the Related GPR55.
@nl
type
label
Magnolia Extract, Magnolol, an ...... Blockade of the Related GPR55.
@en
Magnolia Extract, Magnolol, an ...... Blockade of the Related GPR55.
@nl
prefLabel
Magnolia Extract, Magnolol, an ...... Blockade of the Related GPR55.
@en
Magnolia Extract, Magnolol, an ...... Blockade of the Related GPR55.
@nl
P2093
P2860
P921
P356
P1476
Magnolia Extract, Magnolol, an ...... Blockade of the Related GPR55.
@en
P2093
Alexander Fuchs
Matthias Lehr
Sonja Hinz
Tadeusz Karcz
Uwe Koetter
Viktor Rempel
P2860
P356
10.1021/ML300235Q
P577
2012-11-14T00:00:00Z